India’s drug exporters are seeing a wider spread of demand across regions, with new growth engines complementing established markets during a period of global economic uncertainty, as per PTI reports.
Commerce ministry data shows Nigeria has emerged as one of the fastest-growing destinations, adding $179 million in exports and accounting for over 14% of total export growth in the first 8 months of the current fiscal. Brazil also recorded a rise of nearly $100 million in shipments during April–November FY26.
Overall pharmaceutical exports increased 6.5% to $20.48 billion in April–November 2025–26. The United States remained the single largest destination, contributing over 31% of exports in the period.
Alongside the US, steady gains were reported in France, Canada, Germany and South Africa, supporting a more diversified demand base.
Within Europe, the Netherlands added over $58 million in exports, signalling deeper integration of Indian drugmakers into European distribution networks.
Read More: TCS, Infosys, Wipro and Other IT Companies Book ₹5,000 Crore Hit from New Labour Codes!
With strong contributions from Brazil and Nigeria alongside sustained demand in the US and Europe, India’s pharmaceutical exports are increasingly supported by a broader and more resilient geographic footprint.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Jan 19, 2026, 12:44 PM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
